Dr. Mizukawa is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3333 Burnet Ave
MLC 7013
Cincinnati, OH 45229Phone+1 513-636-1335Fax+1 513-636-3549
Education & Training
- Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2007 - 2010
- Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 2004 - 2007
- University of Utah School of MedicineClass of 2004
Certifications & Licensure
- OH State Medical License 2004 - 2026
- IN State Medical License 2022 - 2025
- KY State Medical License 2021 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 151 citationsTranscription factor RUNX1 promotes survival of acute myeloid leukemia cellsSusumu Goyama, Janet Schibler, Lea Cunningham, Yue Zhang, Yalan Rao
The Journal of Clinical Investigation. 2013-09-03 - 34 citationsA xenograft model of macrophage activation syndrome amenable to anti-CD33 and anti–IL-6R treatmentMark Wunderlich, Courtney A. Stockman, Mahima Devarajan, Navin Ravishankar, Christina Sexton
JCI Insight. 2016-09-23 - 11 citationsIMPDH inhibition activates TLR-VCAM1 pathway and suppresses the development of MLL-fusion leukemia.Xiaoxiao Liu, Naru Sato, Tomohiro Yabushita, Jingmei Li, Yuhan Jia
EMBO Molecular Medicine. 2023-01-11
Journal Articles
- A Non-Myeloablative Conditioning Approach for Long-Term Engraftment of Human and Mouse Hematopoietic Stem CellsBenjamin Mizukawa, Stella Davies, Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: